Search - tctmd.com

Displaying 481 - 500 of 5458

Sort: Relevancy | Date

Presentation TCT 2024

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

Presenter: Jose Henriques

October 29, 2024

Presentation TCT 2024

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Presenter: Jane Wilcox

October 29, 2024

Presentation TCT 2024

Latest Advancements in the Best CLI-Basil Patient Journey

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

Presenter: David Morrow

October 29, 2024

Presentation TCT 2024

TCT 171: Baseline Invasive Hemodynamics and Clinical Outcomes in Transcatheter Tricuspid Valve Replacement? Using the EVOQUE System

Presenter: Omar Abdelhai

October 29, 2024

Presentation TCT 2024

TCT 815: The Impact of Daylight Savings Time on Clinical Outcomes in Patients With Acute Myocardial Infarction: Insights From the NCDR CathPCI Registry

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

Presenter: Yasser Sammour

October 29, 2024

Presentation TCT 2024

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

Presenter: Shashank Sinha

October 29, 2024

Presentation TCT 2024

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

Presenter: Woo Jin Ahn

October 29, 2024

Presentation TCT 2024

Clinical Phenotypes of TR Patients: Same but Different?

Presenter: Laura Davidson

October 29, 2024

Presentation TCT 2024

Best CLI Medical Therapy Subgroup

Presenter: Matthew Menard

October 29, 2024

Presentation TCT 2024

How Can Clinical Trials Mobilize the Diversity Efforts?

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Con: RDN Will Ultimately Be a Niche Therapy

Presenter: Andrew Sharp

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What am I Most Anticipating in Upcoming Clinical Trials?

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Advertisement

Ways in Which DanGer Will and Will Not Influence Clinical Practice in the EU

A Mandate to Generate Evidence for the Use of Temporary Support Devices in Decompensated Chronic Heart Failure Shock

Latest Advancements in the Best CLI-Basil Patient Journey

Ways in which DanGer Will and Will Not Influence Clinical Practice in the US

TCT 171: Baseline Invasive Hemodynamics and Clinical Outcomes in Transcatheter Tricuspid Valve Replacement? Using the EVOQUE System

TCT 815: The Impact of Daylight Savings Time on Clinical Outcomes in Patients With Acute Myocardial Infarction: Insights From the NCDR CathPCI Registry

TCT 426: One-Year Clinical Outcome of Prasugrel Monotherapy After PCI for Chronic Coronary Syndrome in Japanese Population

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

TCT 262: Clinical and Hemodynamic Predictors of Stabilization and Associated Complications in Cardiogenic Shock Patients Supported With Impella 5.5

TCT 427: Comparison of Clinical Outcomes Between Second Generation Zotarolimus- Versus Everolimus-Eluting Stents up to 10-Year Follow-up

Clinical Phenotypes of TR Patients: Same but Different?

Best CLI Medical Therapy Subgroup

How Can Clinical Trials Mobilize the Diversity Efforts?

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Con: RDN Will Ultimately Be a Niche Therapy

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What am I Most Anticipating in Upcoming Clinical Trials?

What Evaluation is Required for Patient Selection for RDN?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content